About this trial
This project aims to develop a novel method for identifying early tissue damage related to pressure ulcer (PU) development in vulnerable patients by measuring biomarkers of inflammation on the skin surface. PUs are common and costly injuries that result from prolonged pressure on the skin. Current methods to assess PU risk are unreliable, and the mechanisms of PU development are not well understood. This project contributes to new knowledge of PU etiology as well as the individual variability at a molecular level combined with new knowledge about nursing actions and clinical factors linked to PU progression and outcomes of prevention. The project will use non-invasive techniques and model-based analysis to identify specific biomolecules that reflect individual susceptibility to pressure exposure in different PU risk scenarios.
Eligibility criteria
Qualifiers
None
Disqualifiers
acute respiratory failure
previous ICU care
pressure ulcer on measurement site
Trial design
Treatments tested in this trial
- non-invasive ventilation teraphy, NIV
Treatment groups
Sponsors and collaborators
Linkoeping University
Lead sponsor
Region Östergötland
Collaborator